Document Detail

Differential regulation of Cu, Zn- and Mn-superoxide dismutases by retinoic acid in normal and psoriatic human fibroblasts.
MedLine Citation:
PMID:  15725579     Owner:  NLM     Status:  MEDLINE    
Superoxide dismutases' (SODs) expression is altered in several diseases including Alzheimer, atherosclerosis, cancer and psoriasis. Previously, we reported a marked increase in Mn-SOD and Cu,Zn-SOD functional activity in human dermal psoriatic fibroblasts. As retinoic acid (RA) has been used in the treatment of psoriasis and a mechanism for its beneficial effects is not understood, we investigated the effects of RA on SOD mRNA and protein expression levels in human normal and psoriatic fibroblasts. Prior to RA exposure, Cu,Zn-SOD protein and mRNA levels were similar in normal compared to psoriatic fibroblasts while Mn-SOD protein and mRNA levels were increased in psoriatic cells. However, in contrast to normal fibroblasts, exposure of psoriatic fibroblasts to 1 microM RA down-regulated Mn-SOD mRNA, and also decreased Mn-SOD activity by approximately 80% with no change in Mn-SOD protein levels. In contrast, Cu,Zn-SOD protein and enzymatic activity were modestly reduced by RA treatment in both normal and psoriatic fibroblasts. Furthermore, RA treatment of psoriatic fibroblasts also caused a decrease in Cu,Zn-SOD steady-state mRNA levels. These results indicate that RA can serve as a regulatory agent to down-regulate the steady-state levels of both Mn-SOD and Cu,Zn-SOD in psoriatic cells. These findings offer a new model for the antiinflammatory activity of RA when used in the treatment of psoriasis.
Pascale Gerbaud; Loïc Petzold; Patrice Thérond; Wayne B Anderson; Danièle Evain-Brion; Françoise Raynaud
Related Documents :
9050989 - Conserved mechanisms of ras regulation of evolutionary related transcription factors, e...
15580519 - Expression and subcellular localization of spred proteins in mouse and human tissues.
11812999 - A functional screen identifies hdril1 as an oncogene that rescues ras-induced senescence.
20709019 - Aldehyde dehydrogenase 1a3 is transcriptionally activated by all-trans-retinoic acid in...
20410309 - Transcriptional regulation of cannabinoid receptor-1 expression in the liver by retinoi...
7958449 - Retinoic acid receptor beta 2 (rar beta 2) null mutant mice appear normal.
9300399 - Basal expression, subcellular distribution, and up-regulation of the proto-oncogene c-j...
9614349 - Collagen biosynthesis by neointimal smooth muscle cells cultured from rabbit aortic exp...
24265759 - Wogonin has multiple anti-cancer effects by regulating c-myc/skp2/fbw7α and hdac1/hdac2...
Publication Detail:
Type:  Journal Article     Date:  2004-12-29
Journal Detail:
Title:  Journal of autoimmunity     Volume:  24     ISSN:  0896-8411     ISO Abbreviation:  J. Autoimmun.     Publication Date:  2005 Feb 
Date Detail:
Created Date:  2005-02-23     Completed Date:  2005-08-03     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8812164     Medline TA:  J Autoimmun     Country:  England    
Other Details:
Languages:  eng     Pagination:  69-78     Citation Subset:  IM    
INSERM U 427, Faculté des Sciences Pharmaceutiques et Biologiques de Paris, Université René Descartes, Paris V, 4 avenue de l'Observatoire, 75270 Paris Cedex 06, France.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Arthritis, Psoriatic / enzymology*,  genetics
Cells, Cultured
Gene Expression Regulation, Enzymologic / drug effects*,  genetics
RNA Stability / drug effects
RNA, Messenger / genetics,  metabolism
Superoxide Dismutase / genetics,  metabolism*
Time Factors
Tretinoin / pharmacology*
Reg. No./Substance:
0/RNA, Messenger; 302-79-4/Tretinoin; EC Dismutase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Tumor necrosis factor-alpha -308 promoter polymorphism contributes independently to HLA alleles in t...
Next Document:  Clinical features and biochemical data of Caucasian children at diagnosis of autoimmune hepatitis.